RXRX250214C00003000 Option on Recursion Pharmaceuticals
RXRX Stock | USD 6.32 0.42 6.23% |
RXRX250214C00003000 is a PUT option contract on Recursion Pharmaceuticals' common stock with a strick price of 3.0 expiring on 2025-02-14. The contract was not traded in recent days and, as of today, has 31 days remaining before the expiration. The option is currently trading at a bid price of $1.75, and an ask price of $4.4. The implied volatility as of the 14th of January 2025 is 31.0.
Recursion |
A put option written on Recursion Pharmaceuticals becomes more valuable as the price of Recursion Pharmaceuticals drops. Conversely, Recursion Pharmaceuticals' put option loses its value as Recursion Stock rises.
Rule 16 of 2025-02-14 Option Contract
The options market is anticipating that Recursion Pharmaceuticals will have an average daily up or down price movement of about 0.24% per day over the life of the option. With Recursion Pharmaceuticals trading at USD 6.32, that is roughly USD 0.0152. If you think that the market is fully understating Recursion Pharmaceuticals' daily price movement you should consider buying Recursion Pharmaceuticals options at that current volatility level of 3.84%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
In The Money Call Option on Recursion Pharmaceuticals
An 'In The Money' option is one with a strike price that the current stock price has already surpassed. Some options investors can hedge their Recursion Pharmaceuticals positions using in-the-money options. They may also want to buy options with some intrinsic value, not just time value. However, because in-the-money options on Recursion Stock have intrinsic value and are priced higher than out-of-the-money options in the same chain, their volatilities are relatively smaller.
Call Contract Name | RXRX250214C00003000 |
Expires On | 2025-02-14 |
Days Before Expriration | 31 |
Delta | 0.900415 |
Vega | 0.003492 |
Gamma | 0.022835 |
Theoretical Value | 4.4 |
Open Interest | 2 |
Strike Price | 3.0 |
Last Traded At | 6.2 |
Current Price Spread | 1.75 | 4.4 |
Rule 16 Daily Up or Down | USD 0.0152 |
Recursion short PUT Option Greeks
Recursion Pharmaceuticals' Option Greeks for the contract ending on 2025-02-14 at a strike price of 3.0 measures the various factors that affect its cost and calculated using a theoretical options pricing model. It helps investors make more informed decisions about whether to trade this option contract or when to trade it. In addition to Recursion Pharmaceuticals' option greeks, its implied volatility helps estimate the risk of Recursion Pharmaceuticals stock implied by the prices of the options on Recursion Pharmaceuticals' stock.
Delta | 0.900415 | |
Gamma | 0.022835 | |
Theta | -0.021153 | |
Vega | 0.003492 | |
Rho | 0.001463 |
Recursion long PUT Option Payoff at expiration
Put options written on Recursion Pharmaceuticals grant holders of the option the right to sell a specified amount of Recursion Pharmaceuticals at a specified price within a specified time frame. The put buyer has a limited loss and, while not fully unlimited gains, as the price of Recursion Stock cannot fall below zero, the put buyer does gain as the price drops. So, purchasing a put option on Recursion Pharmaceuticals is like buying insurance aginst Recursion Pharmaceuticals' downside shift.
Profit |
Recursion Pharmaceuticals Price At Expiration |
Recursion short PUT Option Payoff at expiration
By selling Recursion Pharmaceuticals' put option, the investors signal their bearish sentiment. A short position in a put option written on Recursion Pharmaceuticals will generally make money when the underlying price is above the strike price. Therefore Recursion Pharmaceuticals' put payoff at expiration depends on where the Recursion Stock price is relative to the put option strike price. The breakeven price of 7.4 is the critical point that divides the payoff function into two parts. Below the breakeven price, the payoff is dropping and negative (the seller makes a loss). Above the breakeven price, the payoff line is upward sloping as the option payoff increases in proportion to Recursion Pharmaceuticals' price. Finally, at the strike price of 3.0, the payoff chart is constant and positive.
Profit |
Recursion Pharmaceuticals Price At Expiration |
Recursion Pharmaceuticals Available Call Options
Recursion Pharmaceuticals' option chain is a display of a range of information that helps investors for ways to trade options on Recursion. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Recursion. It also shows strike prices and maturity days for a Recursion Pharmaceuticals against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
Open Int | Strike Price | Current Spread | Last Price | |||
Call | RXRX250321C00001000 | 2 | 1.0 | 3.4 - 8.0 | 7.8 | In |
Call | RXRX250321C00002000 | 5 | 2.0 | 4.3 - 5.1 | 4.9 | In |
Call | RXRX250321C00003000 | 209 | 3.0 | 3.2 - 4.4 | 3.4 | In |
Call | RXRX250321C00004000 | 236 | 4.0 | 2.4 - 3.0 | 2.6 | In |
Call | RXRX250321C00005000 | 605 | 5.0 | 2.0 - 2.15 | 2.0 | In |
Call | RXRX250321C00006000 | 2078 | 6.0 | 1.4 - 1.55 | 1.4 | In |
Call | RXRX250321C00007000 | 3532 | 7.0 | 1.0 - 1.1 | 1.0 | Out |
Call | RXRX250321C00008000 | 3071 | 8.0 | 0.65 - 0.8 | 0.65 | Out |
Call | RXRX250321C00009000 | 3833 | 9.0 | 0.45 - 0.5 | 0.5 | Out |
Call | RXRX250321C00010000 | 4459 | 10.0 | 0.35 - 0.45 | 0.45 | Out |
Call | RXRX250321C00011000 | 1714 | 11.0 | 0.25 - 0.35 | 0.3 | Out |
Call | RXRX250321C00012000 | 948 | 12.0 | 0.0 - 0.2 | 0.2 | Out |
Call | RXRX250321C00013000 | 600 | 13.0 | 0.1 - 0.2 | 0.1 | Out |
Call | RXRX250321C00014000 | 2205 | 14.0 | 0.05 - 0.2 | 0.17 | Out |
Call | RXRX250321C00015000 | 1174 | 15.0 | 0.0 - 0.15 | 0.1 | Out |
Call | RXRX250321C00016000 | 250 | 16.0 | 0.0 - 0.1 | 0.1 | Out |
Call | RXRX250321C00017000 | 879 | 17.0 | 0.0 - 0.15 | 0.05 | Out |
Recursion Pharmaceuticals Corporate Management
Christopher Gibson | CEO CoFounder | Profile | |
Kevin Leggat | Vice Accounting | Profile | |
Janelle Gordon | Vice Operations | Profile | |
Shafique MD | Interim Officer | Profile | |
Nathan Hatfield | Chief Officer | Profile |
Additional Tools for Recursion Stock Analysis
When running Recursion Pharmaceuticals' price analysis, check to measure Recursion Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Recursion Pharmaceuticals is operating at the current time. Most of Recursion Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Recursion Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Recursion Pharmaceuticals' price. Additionally, you may evaluate how the addition of Recursion Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.